Seong J. Yoon
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bacteriophage-mediated restoration of epithelial integrity, DNA damage response, and transcriptomic homeostasis in colon organoids exposed to ETBF and pks + E. coli.
Journal: Scientific reports
Published: October 27, 2025
Development of a Digital Healthcare Management System for Lower-Extremity Amputees: A Pilot Study.
Journal: Healthcare (Basel, Switzerland)
Published: October 26, 2022
Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis.
Journal: Scientific reports
Published: July 12, 2017
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: December 13, 2016
Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period.
Journal: Clinical and experimental pharmacology & physiology
Published: March 26, 2016
Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient.
Journal: Antimicrobial agents and chemotherapy
Published: January 23, 2014
Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1.
Journal: International journal of antimicrobial agents
Published: September 17, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026